Optinosis

Optinosis is dedicated to developing cutting-edge, AI-enabled healthcare solutions focused on the early detection of diseases and the reduction of patient care costs. Optinosis’ innovative technology provides significant value to patients by improving life expectancy through early diagnosis and treatment.

Optinosis delivers substantial benefits to payers, especially those with capitated revenue models such as Medicare Advantage plans. These advantages include reduced patient care costs through early disease detection, extended revenue due to increased patient longevity, and increased risk-adjusted revenue from accurate diagnoses. Optinosis also supports providers, particularly those operating under value-based care models, by increasing their capitated or shared savings revenue through timely disease detection.

With its primary address in Atlanta, US, Optinosis is committed to driving advancements in healthcare through artificial intelligence and innovative software development. We invite the management team at Optinosis to further enrich your company’s presence on our platform with a customized and exclusive company showcase and detailed product listings.